Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for the treatment of diabetic skin ulcers
2011-001736-30Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bosentan in diabetic microangiopathy, sponsored by Medical University of Vienna. Primary endpoint: Percentage reduction in wound area at 16 weeks. Started Oct 2011; status: completed.
02
Drugs
bosentan
03
Conditions
diabetic microangiopathy
Beyond the preview
Go deeper on 2011-001736-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001736-30.